Beneficial effects of eicosapentaenoic acid in coronary heart disease with peripheral vascular diseases: But how and why?

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2786-

  Das, Undurti N ^a,b  

^a UND LIFE SCIENCES   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; FATTY ACID; FATTY ACID DERIVATIVE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN; NITROLIPID DERIVATIVE; OMEGA 3 FATTY ACID; PROTECTIN DERIVATIVE; RESOLVIN DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOSYNTHESIS; DRUG EFFECT; DRUG MECHANISM; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LETTER; LIPID PEROXIDATION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; RISK REDUCTION; SIGNAL TRANSDUCTION;

ADULT; AGED; CORONARY ARTERY DISEASE; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 78649693863     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0644     Document Type: Letter

References (7)

1. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, antiarrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008; 7: 37.
2. Ishikawa Y, Yokoyama M, Saito Y, Matsuzaki M, Origasa H, Oikawa S, et al, for the JELIS Investigators, Japan. Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease: Subanalysis of the JELIS Trial. Circ J 2010; 74: 1451-1457.
3. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: Stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 2002; 13: 2497-2507.
4. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 387-391.
5. Baker PRS, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, et al. Fatty acid transduction of nitric oxide signaling: Multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferatoractivated receptor ligands. J Biol Chem 2005; 280: 42464-42475.
6. Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids: Connecting lipids, inflammation, and cardiovascular disease risk. Curr Cardiovasc Risk Rep 2010; 4: 24-31.
7. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Nishi SP, Martinez JD, et al. Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat. Circulation 2006; 114: 929-935.